Blood Sugar & Glucose Monitor is a health-tracking app for diabetic and prediabetic users to log glucose, medication, and diet on iOS.
The App DNA
What makes this app unique?
Users hire this app to centralize their diabetic routine, but the subscription-only model forces a high-friction decision before they can evaluate the tool's utility.
For Individuals with diabetes or prediabetes requiring a centralized tool for glucose logging, medication management, and dietary tracking.
What does it look like?
Key features
Logs and monitors daily blood sugar levels and trends.
Customizable alerts for medication intake and insulin injections.
Identifies patterns in glucose data to assist with health decisions.
How much does it cost?
Strict subscription model with no free tier, gating all functionality behind a $4.99 weekly recurring payment.
Velocity
Dormant developmentUX improvementsShow more...
The app has not received a public update in 1,137 days, placing it firmly in the zombie category. The last recorded release introduced medication reminders and predictive analytics, but development has since ceased entirely. There is no evidence of ongoing maintenance, feature expansion, or live operations support.
Who built it?
Iryna Bernova
4 apps tracked · Utilities
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Blood Sugar & Glucose Monitor
How's the Utilities market?
The app occupies a niche health-utility space, but its 5-star rating on only 19 reviews suggests a limited, unverified user base. The lack of updates since 2023 places it at a disadvantage against actively maintained health trackers.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Blood Sugar & Glucose Monitor
Where is it heading?
The health-tracking market is consolidating around active, wearable-integrated platforms, leaving this app exposed. Without a shift to a freemium model and a return to regular release cycles, the app will continue to lose relevance to competitors.
- The 37-month update silence suggests abandonment, which drives churn as users seek platforms with active security and feature support.
The SWOT
- Centralized health-logging architecture simplifies daily diabetic routine management.
- Predictive analytics feature provides actionable health pattern identification.
- Introduce a limited free tier to improve top-of-funnel conversion.
- Integrate wearable health data to improve predictive accuracy.
Next best moves
Pivot pricing model to a freemium structure because the current $4.99/week gate prevents user acquisition → increase install-to-subscription conversion.
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of updates is not just a failure of maintenance…
Read the full takeSince the last report: The report now incorporates specific user rating data and expands the SWOT analysis to better reflect the competitive risks of the app's maintenance-mode status.
Bottom line
The app provides a functional health-tracking suite, but the subscription-only model and lack of updates since 2023 limit its growth potential, so the PM should prioritize a freemium pivot to lower the acquisition barrier.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated